Toon Aerts signs for new team as doping suspension nears end

Belgian cyclo-cross rider free to compete from February 16 after two-year ban

Clock16:30, Friday 1st December 2023
Toon Aerts hasn't raced since February 2022

© Velo Collection (TDW) / Getty Images

Toon Aerts hasn't raced since February 2022

Belgian cyclo-cross rider Toon Aerts has reportedly signed for a new team and intends to race again as soon as his two-year doping suspension ends in February of next year.

According to Het Nieuwsblad, Aerts has signed a new two-year contract with Deschacht-Hens-Maes, to start on February 16 once his two-year ban for the use of the banned substance letrozole, in January of 2022, expires.

Aerts, who previously rode for Baloise Trek Lions, was only officially found guilty of an anti-doping violation in August 2023, after a lengthy investigation by the UCI Anti-Doping Tribunal, during which the 30-year-old maintained that he had tested positive due to contamination.

The positive test for letrozole, an aromatase inhibitor that can increase testosterone levels, was detected just before the UCI Cyclo-cross World Championships in 2022, where he placed sixth. That result, along with all his results from January 22 onwards, have since been stripped.

Despite Aerts’ attempts to protest his innocence, the UCI investigation concluded that he had "failed to establish how [it] entered his body" and handed him a ban.

Because Aerts had effectively self-suspended and been placed on ‘inactive’ status by his team from the date they were notified of the positive test, February 16, 2022, the duration of his ban was backdated and is therefore set to expire on February 16, 2024.

Het Nieuwsblad reports that Aerts could be back in action the very next day after his ban expired, with the Exact Cross Sint-Niklaas taking place on February 17.

Before his ban, Aerts was one of the most successful riders in the cyclo-cross field, winning back-to-back World Cup overall titles in 2019 and 2020. Since being suspended, he has been working part-time as a PE teacher.

During his suspension, another rider and Aerts’ compatriot, Shari Bossuyt, also tested positive for letrozole earlier this year, and is currently under investigation by the UCI, with no decision made yet. The pair share a manager. Bossuyt also maintains that her positive is the result of contamination, and Aerts has publicly supported the 23-year-old.

Related Content

Link to Giro d’Italia stage 16 preview: Bad weather threatens to affect already-shortened Stelvio stage
A big day is ahead on stage 16 of the Giro d'Italia

Giro d’Italia stage 16 preview: Bad weather threatens to affect already-shortened Stelvio stage

Poor weather contingency plans in place as a tough day and steep finish beckons

Clock
Link to Dani Martínez: 'The battle for the Giro d'Italia is almost done, now it is for second and third'
Dani Martínez and Geraint Thomas are split by only a matter of seconds in the overall standings

Dani Martínez: 'The battle for the Giro d'Italia is almost done, now it is for second and third'

Colombian climber all but concedes the maglia rosa to Tadej Pogačar, after Queen stage leaves Bora-Hansgrohe man in a three-way battle for the podium

Clock
Link to Tadej Pogačar hints at conservative approach as Giro d’Italia domination enters third week
Tadej Pogačar leaves the rest behind on Sunday's mountain finish

Tadej Pogačar hints at conservative approach as Giro d’Italia domination enters third week

"Let's see what's on the cards," says Slovenian as final week approaches

Clock
Link to Giro d’Italia: ‘Crunch time’ for Ben O’Connor as he chases podium in final week
Australian Ben O'Connor is determined to take a podium spot at this year's Giro d'Italia

Giro d’Italia: ‘Crunch time’ for Ben O’Connor as he chases podium in final week

Australian currently 47 seconds off third place and ‘not afraid’ of challenges to come

Clock
Subscribe to the GCN Newsletter

Get the latest, most entertaining and best informed news, reviews, challenges, insights, analysis, competitions and offers - straight to your inbox